BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1570 related articles for article (PubMed ID: 24798950)

  • 1. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
    Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
    Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.
    Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM
    Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue macrophages.
    Zeyda M; Stulnig TM
    Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.
    Khodabandehloo H; Gorgani-Firuzjaee S; Panahi G; Meshkani R
    Transl Res; 2016 Jan; 167(1):228-56. PubMed ID: 26408801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
    Sell H; Eckel J
    Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory mechanisms in obesity.
    Gregor MF; Hotamisligil GS
    Annu Rev Immunol; 2011; 29():415-45. PubMed ID: 21219177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NLRP3 inflammasome and visceral adipose tissue].
    Esser N; Legrand-Poels S; Piette J; Paquot N; Scheen AJ
    Rev Med Liege; 2014; 69 Spec No():57-61. PubMed ID: 25796800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].
    León-Pedroza JI; González-Tapia LA; del Olmo-Gil E; Castellanos-Rodríguez D; Escobedo G; González-Chávez A
    Cir Cir; 2015; 83(6):543-51. PubMed ID: 26159364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.
    Kim MS; Lee MS; Kown DY
    Ann N Y Acad Sci; 2011 Jul; 1229():140-6. PubMed ID: 21793849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of Adipose Tissue during Metabolic Syndrome.
    Ghazarian M; Luck H; Revelo XS; Winer S; Winer DA
    Turk Patoloji Derg; 2015; 31 Suppl 1():172-80. PubMed ID: 26177326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.
    Garbossa SG; Folli F
    Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and function of macrophages in the metabolic syndrome.
    Bhargava P; Lee CH
    Biochem J; 2012 Mar; 442(2):253-62. PubMed ID: 22329799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.